Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note
Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO. In this note, we will talk about the trading dynamics.
423 Views
Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...
663 Views
Concord Biotech IPO - RHP Updates - Continued Growing Although Concentration Risk Remains Elevated
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. Concord is an India-based biopharma firm, which develops and...
362 Views
ECM Weekly (26th Feb 2023) - Japan Post Bank/Holding, Amvis, Pertamina, Zeekr, Honasa, Fangzhou, TVS
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
445 Views
Honasa Consumer Pre-IPO - The Negatives - Ad Spending Keeping Profits Low
Honasa Consumer (HC) is looking to raise about US$350m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.
351 Views